Bottom line
What is IVFAX's expense ratio?
IVFAX's expense ratio is 1.11%, or about $111 a year on every $10,000 invested. That is more expensive than 79% of dividend & equity income funds we track (median 0.74%). This share class also charges a front-end sales load of up to 5.5%, taken from your investment when you buy.
Updated Jan 23, 2026
IVFAX fee table
| Net expense ratio | 1.11% |
|---|---|
| Gross expense ratio | 1.25% |
| Management fee | 0.74% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.51% |
| Fee waiver / reimbursement | -0.14% |
| Max front-end sales load | 5.5% |
| Max deferred sales charge | 0% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Jan 23, 2026
What IVFAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| IVFAX | $670 | $925 | $1,199 | $1,978 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.11% expense ratio costs roughly $60,900 in lost growth, versus about $41,900 for the median dividend & equity income fund (0.74%).